Anti-inflammatory role of the isoflavone diadzein in lipopolysaccharide- stimulated microglia: Implications for parkinson's disease

Neurotoxicity Research

Volumn 23, Issue 2, 2013, Pages 145-153

  Chinta, Shankar J ^a   Ganesan, Abirami ^a   Reis Rodrigues, Pedro ^a   Lithgow, Gordon J ^a   Andersen, Julie K ^a  

^a BUCK INSTITUTE FOR RESEARCH ON AGING   (United States)

Author keywords

Diadzein; Inflammation; Isoflavones; Lipopolysaccharide (LPS); Microglia; Neuroprotection; Parkinson's disease (PD)

Indexed keywords

DAIDZEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LEVEL; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; MICROGLIA; MOUSE; NERVE CELL STIMULATION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL;

ANIMALIA; GLYCINE MAX; MURINAE;

EID: 84878474759     PISSN: 10298428     EISSN: 14763524     Source Type: Journal    
DOI: 10.1007/s12640-012-9328-5     Document Type: Article

References (39)

1. Axelson M, Sjovall J, Gustafsson BE, Setchell KD (1984) Soya: a dietary source of the non-steroidal oestrogen equol in man and animals. J Endocrinol 102:49-56
2. Bhat NR, Zhang P, Lee JC, Hogan EL (1998) Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures. J Neurosci 18(5):1633-1641
3. Bi W, Zhu L, Wang C, Liang Y, Liu J, Shi Q, Tao E (2011) Rifampicin inhibits microglial inflammation and improves neuron survival against inflammation. Brain Res 13(1395):12-20
4. Blasi E, Barluzzi R, Bocchini V, Mazzolla R, Bistoni F (1990) Immortalization of murine microglial cells by a v-raf / v-myccarrying retrovirus. Journal of Neuroimmunology 27(2-3):229-237
5. Blum-Degen D, Muller T, Kuhn W, Gerlach M, Przuntek H, Riederer P (1995) Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. Neurosci Lett 202:17-20
6. Carta AR, Frau L, Pisanu A, Wardas J, Spiga S, Carboni E (2011) Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model. Neuroscience 27(194):250-261
7. Chen HQ, Jin ZY, Li GH (2007) Biochanin A protects dopaminergic neurons against lipopolysaccharide-induced damage through inhibition of microglia activation and proinflammatory factors generation. Neurosci Lett 417(2):112-117
8. Chinta SJ, Andersen JK (2006) Reversible inhibition of mitochondrial complex I activity following chronic dopaminergic glutathione depletion in vitro: implications for Parkinson's disease. Free Radic Biol Med 41(9):1442-1448
9. Dobbs RJ, Charlett A, Purkiss AG, Dobbs SM, Weller C, Peterson DW (1999) Association of circulating TNF-alpha and IL-6 with ageing and Parkinsonism. Acta Neurol Scand 100(1):34-41
10. Gao HM, Jiang J, Wilson B, Zhang W, Hong JS, Liu B (2002) Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem 81:1285-1297
11. Guyton KZ, Gorospe M, Kensler TW, Holbrook NJ (1996) Mitogen-activated protein kinase (MAPK) activation by butylated hydroxytoluene hydroperoxide: implications for cellular survival and tumor promotion. Cancer Res 56:3480-3485
12. Hirsch EC, Hunot S (2009) Neuroinflammation in Parkinson's disease: a target for neuroprotection? Lancet Neurol 8:382-397
13. Hunot S, Dugas N, Faucheux B, Hartmann A, Tardieu M, Debre P, Agid Y, Dugas B, Hirsch EC (1999) FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. J Neurosci 19:3440-3447
14. Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y (2003) Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol 106(6):518-526
15. Jeohn GH, Kong LY, Wilson B, Hudson P, Hong JS (1998) Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol 85:1-10
16. Jiang Q, Payton-Stewart F, Elliott S, Driver J, Rhodes LV, Zhang Q, Zheng S, Bhatnagar D, Boue SM, Collins-Burow BM, Sridhar J, Stevens C, McLachlan JA, Wiese TE, Burow ME, Wang G (2010) Effects of 7-O substitutions on estrogenic and anti-estrogenic activities of daidzein analogues in MCF-7 breast cancer cells. J Med Chem 53(16):6153-6163
17. Jung JS, Shin JA, Park EM, Lee JE, Kang YS, Min SW, Kim DH, Hyun JW, Shin CY, Kim HS (2010) Anti-inflammatory mechanism of ginsenoside Rh1 in lipopolysaccharide-stimulated microglia: critical role of the protein kinase A pathway and hemeoxygenase-1 expression. J Neurochem 115(6):1668-1680
18. Kim WJ, Back SH, Kim V, Ryu I, Jang SK (2005) Sequestration of TRAF2 into stress granules interrupts tumor necrosis factor signaling under stress conditions. Mol Cell Biol 25:2450-2462
19. Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19(8):312-318
20. Levis S, Strickman-Stein N, Ganjei-Azar P, Xu P, Doerge DR, Krischer J (2011) Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms: a randomized, double-blind trial. Arch Intern Med 171(15):1363-1369
21. Liggins J, Bluck LJ, Runswick S et al (2000) Daidzein and genistein content of fruits and nuts. J Nutr Biochem 11:326-331
22. Liggins J, Mulligan A, Runswick S, Bingham SA (2002) Daidzein and genistein content of cereals. Eur J Clin Nutr 56:961-966
23. Moon DO, Park SY, Lee KJ, Heo MS, Kim KC, Kim MO, Lee JD, Choi YH, Kim GY (2007) Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int Immunopharmacol 7(8):1092-1101
24. Moore DJ, West AB, Dawson VL, Dawson TM (2005) Molecular pathophysiology of Parkinson's disease. Annu Rev Neurosci 28:57-87
25. Neumann J, Sauerzweig S, Rönicke R, Gunzer F, Dinkel K, Ullrich O, Gunzer M, Reymann KG (2008) Microglia cells protect neurons by direct engulfment of invading neutrophil granulocytes: a new mechanism of CNS immune privilege. J Neurosci 28(23):5965-5975
26. Occhiuto F, Zangla G, Samperi S, Palumbo DR, Pino A, De Pasquale R, Circosta C (2008) The phytoestrogenic isoflavones from Trifolium pratense L. (Red clover) protects human cortical neurons from glutamate toxicity. Phytomedicine 15(9):676-682
27. Occhiuto F, Palumbo DR, Samperi S, Zangla G, Pino A, De Pasquale R, Circosta C (2009) The isoflavones mixture from Trifolium pratense L. protects HCN 1-A neurons from oxidative stress. Phytother Res. 23(2):192-196
28. Peng J, Mao XO, Stevenson FF, Hsu M, Andersen JK (2004) The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway. J Biol Chem 279(31):32626-32632
29. Qian L, Flood PM, Hong JS (2010) Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy. J Neural Transm 117(8):971-979
30. Qin L, Liu Y, Wang T, Wei SJ, Block ML, Wilson B, Liu B, Hong JS (2004) NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J Biol Chem 279:1415-1421
31. Schreck R, Rieber P, Baeuerle PA (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J 10:2247-2258
32. Schreihofer DA, Redmond L (2009) Soy phytoestrogens are neuroprotective against stroke-like injury in vitro. Neuroscience 158(2):602-609
33. Silvina L, Nancy S.-S, Parvin G.-A, Ping X, Daniel RD, Jeffrey K (2011). Soy Isoflavones in the Prevention of Menopausal Bone Loss and Menopausal Symptoms. A Randomized, Double-blind Trial. Arch Intern Med 171(15):1363-1369. doi: 10.1001/archinternmed.2011.330
34. Sriram K, Miller DB, O'Callaghan JP (2006) Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor-alpha. J Neurochem 96(3):706-718
35. Thomas B, Beal MF (2011) Molecular insights into Parkinson's disease. F1000 Med Rep 3:7
36. Wang MJ, Lin WW, Chen HL, Chang YH, Ou HC, Kuo JS et al (2002) Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation. Eur J Neurosci 16:2103-2112
37. Wang X, Chen S, Ma G, Ye M, Lu G (2005) Genistein protects dopaminergic neurons by inhibiting microglial activation. NeuroReport 16(3):267-270
38. Wang S, Wang H, Guo H, Kang L, Gao X, Hu L (2011) Neuroprotection of scutellarin is mediated by inhibition of microglial inflammatory activation. Neuroscience 30(185):150-160
39. Xie Z, Smith CJ, Van Eldik LJ (2004) Activated glias induce neuron death via MAP kinase signaling pathways involving JNK and p38. Glia 45(2):170-179